new combo drug, Juvisync (JU-vih-sink), for treating diabetes
You'll see a new combo drug, Juvisync (JU-vih-sink), for treating diabetes.
Juvisync combines sitagliptin (Januvia) and simvastatin (Zocor) in one tab. It's the first "gliptin-statin" combo on the market.
Using these drugs together makes sense. Diabetes is a big risk factor for developing heart disease...and so is high cholesterol.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote